Products of Conception

Studies foetal tissue from a lost pregnancy to check whether the miscarriage was the result of chromosomal aneuploidy

Scroll Down


  • 50% of miscarriages in the first trimester are caused by chromosomal abnormalities.
  • For women undergoing assisted reproduction treatment this proportion is 60% and increases with the woman's age.
  • All 24 chromosomes are analysed to identify the reason for the pregnancy loss.
  • The mother's blood is taken to rule out any contamination in the foetal sample.
  • Information from the POC test can help patients choose future reproductive options to ensure a healthy pregnancy.


  • Results are obtained in 99% of cases.
  • Results are available quickly as cell culture is not required.
  • False negative results caused by maternal contamination can be ruled out.
  • STR microsatellite (DNA fingerprinting) technology is used to identify the maternal or foetal origin of the material analysed.
  • NGS has higher resolution than a conventional karyotype.
  • Can be performed on twin pregnancies.


The POC test is suitable for:

  • Women who have suffered a pregnancy loss.
  • Women who have experienced recurrent miscarriages.
  • Couples undergoing assisted reproduction treatment, as useful information from the POC test report can guide their future treatment choices.



Report will be delivered in 15 working days after receiving the samples in our lab

Downloads & publications



Step by Step Provider

Step by Step Provider

Report Example

Report Example


Relevant data





Of all recognised pregnancies are miscarriages

Of first trimester pregnancy losses are due to chromosomal abnormalities

Of first trimester pregnancy losses are due to chromosomal abnormalities after assisted reproduction treatments

Analysis of all 24 chromosomes

Do you want to start using our Genetic Services?

For further assistance please contact our customer support team by phone or e-mail

Contact us

Igenomix is in the media

Igenomix is not affiliated with any news outlet or publication identified above. News coverage does not constitute an endorsement of Igenomix or its products.

Newsletter subscription